TECHNOLOGYASIA TIMES
East Asia’s biotech autonomy push is already stunting innovation
The US-China technology rivalry is expanding into biotechnology, with export controls and investment restrictions creating a new strategic competition front. East Asia's push for biotech autonomy risks slowing innovation, highlighted by a 2025 US restriction on China's access to advanced biotechnology equipment.
Mentioned
Related Signal
Adjacent reporting
- China’s biotech industry sees global expansion as unstoppable, despite US pressure
- Moolenaar Calls to Restrict American Investment in China’s Biotechnology Companies
- China’s biotech industry sees global expansion as unstoppable, despite US pressure
- The next tech war? Why biotech may become a new US-China battleground
- Cross-border biotech deals grow more complex as US targets China investment links